The Prevalence of Prenatal Opioid and Other Drug Use in Utah

Abstract

Objectives Determine the prevalence of prenatal opioid and other drug positivity among women delivering infants in Utah and compare the findings with national data.

Study Design Umbilical cord tissue samples and nonidentifiable demographic data were collected anonymously in 13 labor and delivery units throughout Utah. Samples were analyzed for opioids, amphetamines, cannabinoids, cocaine, phencyclidine, barbiturates, benzodiazepines, propoxyphene, and alcohol biomarkers.

Results Fifty-eight (6.8%) of 850 umbilical cord samples were positive for one or more substances. Opioids were the most frequently detected drugs (4.7%). Fewer samples were positive for alcohol (0.4%), methamphetamine (0.1%), cocaine (0.1%), and marijuana (0.4%).

Conclusion Opioids were the most frequently detected drugs at delivery. Although some of the samples positive for opioids might have been a result of intrapartum exposure, a significant number were positive for opioids that are not given during labor. This parallels the increasing nonmedical use of prescription pain medications in the general population and has important implications for neonates because of the potential for significant morbidity secondary to neonatal abstinence syndrome.

Keywords

prenatal - drug use - opioids - umbilical cord drug screening

• References

• 1 Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11–4658. Rockville, MD. 2011. Available at: http://www.samhsa.gov/data/NSDUH/2k10NSDUH/tabs/Sect1peTabs54to58.pdf . Accessed February 24, 2012
• 2 Substance Abuse and Mental Health Services Administration. Summary of Findings from the 2000 National Household Survey on Drug Abuse. Office of Applied Studies, NHSDA Series H-13, DHHS Publication No. (SMA) 01–3549. Rockville, MD. Available at: http://www.samhsa.gov/data/nhsda/2kdetailedtabs/Vol_1_Part_1/sect1v1.htm#1.1b . Accessed February 24, 2012
• 3 Utah Department of Human Services Division of Substance Abuse and Mental Health. Annual Report 2010. http://www.dsamh.utah.gov/docs/2010_annual_report_for_web.pdf . Accessed February 24, 2012
• 4 Hudak ML, Tan RC. The committee on drugs; the committee on fetus and newborn. Neonatal drug withdrawal. Pediatrics 2012; 129: e540-e560
• 5 USDTL Testing Services. Available at: http://www.usdtl.com/cordstatsm.html . Accessed February 24, 2012
• 6 Le NL, Reiter A, Tomlinson K, Jones J, Moore C. The detection of oxycodone in meconium specimens. J Anal Toxicol 2005; 29: 54-57
• 7 Wright TE, Milam KA, Rougee L, Tanaka MD, Collier AC. Agreement of umbilical cord drug and cotinine levels with maternal self-report of drug use and smoking during pregnancy. J Perinatol 2011; 31: 324-329
• 8 Gray TR, LaGasse LL, Smith LM , et al. Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study. Ther Drug Monit 2009; 31: 769-775
• 9 Montgomery D, Plate C, Alder SC, Jones M, Jones J, Christensen RD. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. J Perinatol 2006; 26: 11-14
• 10 Montgomery DP, Plate CA, Jones M , et al. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey. J Perinatol 2008; 28: 750-753
• 11 Kellogg A, Rose CH, Harms RH, Watson WJ. Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol 2011; 204: 259 , e1–e4
• 12 Prescription Drug Abuse, Florida's Health Crisis. Available at: http://leaonrdmc.org/docs/pdf/Aronberg%20Drug%20Abuse%Training.pdf">http://leaonrdmc.org/docs/pdf/Aronberg%20Drug%20Abuse%Training.pdf . Accessed July 27, 2012